American Heart Association's Life's Simple 7 and risk of venous thromboembolism: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study

Journal of the American Heart Association
N C OlsonNeil A Zakai

Abstract

The American Heart Association's Life's Simple 7 metric is being used to track the population's cardiovascular health (CVH) toward a 2020 goal for improvement. The metric includes body mass index (BMI), blood pressure, cholesterol, glucose, physical activity (PA), cigarette smoking, and diet. We hypothesized a lower risk of venous thromboembolism (VTE) with favorable Life's Simple 7 scores. REGARDS recruited 30,239 black and white participants ≥45 years of age across the United States in 2003-2007. A 14-point summary score for Life's Simple 7 classified participants into inadequate (0 to 4 points), average (5 to 9 points), and optimal (10 to 14 points) categories. Hazard ratios (HRs) of incident VTE were calculated for these categories, adjusting for age, sex, race, income, education, and region of residence. For comparison, HRs of VTE were calculated using the Framingham 10-year coronary risk score. There were 263 incident VTE cases over 5.0 years of follow-up; incidence rates per 1000 person-years declined from 2.9 (95% confidence interval [CI], 2.3 to 3.7) among those in the inadequate category to 1.8 (95% CI, 1.4 to 2.4) in the optimal category. Compared to the inadequate category, participants in the average category had a...Continue Reading

References

Feb 26, 1997·JAMA : the Journal of the American Medical Association·S Z GoldhaberC H Hennekens
Aug 28, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Carine J M DoggenBruce M Psaty
Mar 22, 2005·Diabetologia·V PetrauskieneJ W Eriksson
Jul 2, 2005·Neuroepidemiology·Virginia J HowardGeorge Howard
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·K J van StralenF R Rosendaal
Dec 13, 2005·American Journal of Epidemiology·Lindsay M MortonPatricia Hartge
Apr 17, 2007·Seminars in Hematology·Mary Cushman
Aug 19, 2007·Journal of Thrombosis and Haemostasis : JTH·K J van StralenC J M Doggen
Dec 19, 2007·Circulation·Walter AgenoPieter W Kamphuisen
Jan 9, 2008·Journal of the American Geriatrics Society·Karlijn J van StralenSusan R Heckbert
Jan 22, 2010·Circulation·Donald M Lloyd-JonesUNKNOWN American Heart Association Strategic Planning Task Force and Statistics Committee
Mar 19, 2011·Annals of Neurology·Virginia J HowardGeorge Howard
Apr 16, 2011·Journal of the American College of Cardiology·Aaron R FolsomUNKNOWN ARIC Study Investigators
Jul 30, 2011·Journal of Thrombosis and Haemostasis : JTH·N A Zakai, L A McClure
Dec 27, 2011·Seminars in Thrombosis and Hemostasis·Willem M LijferingSuzanne C Cannegieter
Dec 27, 2011·Seminars in Thrombosis and Hemostasis·Margaret A Allman-Farinelli
Apr 30, 2013·Seminars in Thrombosis and Hemostasis·Sigrid K BraekkanFrits R Rosendaal
May 25, 2013·Journal of the American Society of Nephrology : JASN·Paul MuntnerDavid G Warnock
Jun 8, 2013·Stroke; a Journal of Cerebral Circulation·Ambar KulshreshthaMary Cushman

❮ Previous
Next ❯

Citations

May 5, 2016·Current Cardiology Reports·Steven A Claas, Donna K Arnett
Feb 22, 2017·Progress in Cardiovascular Diseases·Ross ArenaAndrew P Hills
Jul 10, 2018·Journal of Thrombosis and Haemostasis : JTH·K L CheungM Cushman
Feb 20, 2018·Journal of the American Heart Association·Yejin MokKunihiro Matsushita
Feb 2, 2018·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
Sep 2, 2017·Journal of the American Heart Association·Barbara RiegelUNKNOWN American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; and Council
Feb 1, 2019·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
Aug 27, 2019·Journal of Thrombosis and Haemostasis : JTH·Line H EvensenJohn-Bjarne Hansen
Jan 30, 2020·Circulation·Salim S ViraniUNKNOWN American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
Sep 8, 2018·Journal of Thrombosis and Haemostasis : JTH·L H EvensenJ-B Hansen
Feb 8, 2019·European Journal of Preventive Cardiology·Magdalena JohanssonMarcus Lind
May 16, 2019·European Journal of Preventive Cardiology·Domenico Tuttolomondo
Nov 16, 2019·European Journal of Epidemiology·Setor K KunutsorJari A Laukkanen
Sep 4, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Christina R EvansMary Cushman
Nov 17, 2020·Journal of the American Heart Association·Aaron R Folsom, Mary Cushman
Jan 4, 2021·Journal of Thrombosis and Thrombolysis·H Danin-MankowitzP Wändell
Jan 28, 2021·Circulation·Salim S ViraniUNKNOWN American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
Jun 1, 2021·Expert Review of Cardiovascular Therapy·Erin D Michos, Sadiya S Khan

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy

Software Mentioned

Life Simple 7
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.